{"url_path":"/sec/mvis/8-k/2026-06-01/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/65770/0001493152-26-026656-index.html","accession_number":"0001493152-26-026656","cik":"0000065770","ticker":"MVIS","issuer_name":"MICROVISION, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/65770/0001493152-26-026656-index.html","primary_entity_key":"0000065770","primary_entity_name":"MICROVISION, INC."},"word_count":447,"has_tables":true,"body_markdown":"**Item\n8.01. Other Events.**\n\n** **\n\nOn\nJune 1, 2026, MicroVision, Inc., a Delaware corporation (the “Company” or “MicroVision”), issued a press release\nannouncing that it plans to seek approval for an amendment to the Company’s certificate of incorporation to provide MicroVison’s\nBoard of Directors with the right to effect a reverse stock split of the Company’s common stock, par value $0.01 per share, at\na ratio of not less than 1-for-5 or more than 1-for-15, with the exact ratio to be determined by the Board of Directors. The press release\nis attached hereto as Exhibit 99.1 and is incorporated herein by reference.\n\n \n\nMicroVision’s\nBoard of Directors has set May 28, 2026 as the record date for shareholders entitled to vote at the Annual Meeting of Shareholders. The\ntime and other details regarding the Annual Meeting will be communicated to shareholders via preliminary and definitive proxy materials\nwhich will be filed with, and will be subject to review by, the U.S. Securities and Exchange Commission (the “SEC”).\n\n \n\n**Solicitation\nMaterial**\n\n \n\nThis\ncommunication may be deemed to be solicitation material in connection with the proposal to be submitted to MicroVision shareholders at\nits Annual Meeting seeking approval of an amendment to the Company’s certificate of incorporation to effect a reverse stock split.\nIn connection with the proposal, MicroVision plans to file a preliminary proxy statement on Schedule 14A with the SEC. The Company expects\nto file its definitive proxy material in due course. Shareholders are encouraged to read the preliminary proxy statement and all other\nrelevant documents filed with the SEC when they become available, including the definitive proxy statement, because they will contain\nimportant information about the proposal. Shareholders may obtain a free copy of the proxy statement and other documents that the Company\nfiles with the SEC at the SEC’s website (www.sec.gov) or from the Company by accessing information included on the Investor Relations\nwebsite (ir.microvision.com).\n\n \n\nMicroVision\nand certain of its directors and executive officers may be deemed to be participants in the solicitation of proxies in connection with\nthe proposal to be submitted to MicroVision’s shareholders at its 2026 Annual Meeting of Shareholders. Information about the directors\nand executive officers of MicroVision is set forth in its Annual Report on Form 10-K filed with the SEC on March 4, 2026, as amended\n(the “2025 Form 10-K”), under the heading “Directors, Executive Officers and Corporate Governance.” Investors\nmay obtain additional information regarding the interests of such participants by reading the 2025 Form 10-K, the preliminary proxy statement\nand the definitive proxy statement, when it becomes available. MicroVision has also retained Saratoga Proxy Consulting LLC to assist\nin the solicitation of proxies at an estimated cost of $10,000 plus expenses."}